OpSCF
Latest Information Update: 01 Dec 2023
At a glance
- Originator Opsidio
- Class Anti-inflammatories; Antifibrotics; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Stem cell factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Atopic dermatitis
- Preclinical Fibrosis; Inflammation